1. Home
  2. NVAX vs AHCO Comparison

NVAX vs AHCO Comparison

Compare NVAX & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$10.09

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo AdaptHealth Corp.

AHCO

AdaptHealth Corp.

HOLD

Current Price

$10.42

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
AHCO
Founded
1987
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
NVAX
AHCO
Price
$10.09
$10.42
Analyst Decision
Hold
Strong Buy
Analyst Count
9
4
Target Price
$11.33
$13.25
AVG Volume (30 Days)
4.2M
1.5M
Earning Date
05-20-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
309.76
N/A
EPS
2.58
N/A
Revenue
$1,123,479,000.00
$3,244,857,000.00
Revenue This Year
N/A
$9.00
Revenue Next Year
N/A
$6.93
P/E Ratio
$3.97
N/A
Revenue Growth
64.69
N/A
52 Week Low
$5.01
$7.11
52 Week High
$11.85
$11.17

Technical Indicators

Market Signals
Indicator
NVAX
AHCO
Relative Strength Index (RSI) 55.12 59.81
Support Level $7.81 $8.67
Resistance Level $10.42 $10.62
Average True Range (ATR) 0.73 0.46
MACD -0.02 0.12
Stochastic Oscillator 36.18 82.66

Price Performance

Historical Comparison
NVAX
AHCO

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Share on Social Networks: